{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:58:13Z","timestamp":1791003493696,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03462-7","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T08:10:33Z","timestamp":1731139833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti\u2011phenolic glycolipid\u2011I seropositivity among household contacts of leprosy patients in Egypt"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7959-1998","authenticated-orcid":false,"given":"Eman Mohamed","family":"Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3528-5769","authenticated-orcid":false,"given":"Haidy","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6536-8538","authenticated-orcid":false,"given":"Mai Ebrahim","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7099-837X","authenticated-orcid":false,"given":"Rasha E.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-6915","authenticated-orcid":false,"given":"Heba Mahmoud","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"3462_CR1","doi-asserted-by":"publisher","unstructured":"Franco-Paredes C, Rodriguez-Morales AJ (2016) Unsolved matters in leprosy: a descriptive review and call for further research. Ann Clin Microbiol Antimicrob 15(1):33. https:\/\/doi.org\/10.1186\/s12941-016-0149-x","DOI":"10.1186\/s12941-016-0149-x"},{"key":"3462_CR2","doi-asserted-by":"publisher","unstructured":"Rahfiludin MZ, Saraswati LD, Ginandjar P (2017) Duration of contact, type of Leprosy, and Floor Condition as Risk factors for Leprosy Sero-positivity. Jurnal Kesehatan Masyarakat 13(2). https:\/\/doi.org\/10.15294\/kemas.v13i2.7791","DOI":"10.15294\/kemas.v13i2.7791"},{"key":"3462_CR3","doi-asserted-by":"publisher","unstructured":"Oktaria S, Hurif NS, Naim W, Thio HB, Nijsten TEC, Richardus JH (2018) Dietary diversity and poverty as risk factors for leprosy in Indonesia: a case-control study. PLoS Negl Trop Dis 12(3):e0006317. https:\/\/doi.org\/10.1371\/journal.pntd.0006317","DOI":"10.1371\/journal.pntd.0006317"},{"key":"3462_CR4","doi-asserted-by":"publisher","unstructured":"Wang Z et al (2016) A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy. Nat Commun 7:13760. https:\/\/doi.org\/10.1038\/ncomms13760","DOI":"10.1038\/ncomms13760"},{"key":"3462_CR5","doi-asserted-by":"publisher","unstructured":"de Sousa JR, Sotto MN, Sim\u00f5es JA, Quaresma (2017) Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease, Front Immunol, 8. https:\/\/doi.org\/10.3389\/fimmu.2017.01635","DOI":"10.3389\/fimmu.2017.01635"},{"key":"3462_CR6","doi-asserted-by":"publisher","unstructured":"Gama RS et al (2018) Dec., High frequency of M. leprae DNA detection in asymptomatic household contacts, BMC Infect Dis, 18(1):153, https:\/\/doi.org\/10.1186\/s12879-018-3056-2","DOI":"10.1186\/s12879-018-3056-2"},{"key":"3462_CR7","doi-asserted-by":"publisher","unstructured":"van Hooij A, Geluk A (2021) In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae. Immunol Rev 301(1):175\u2013192. https:\/\/doi.org\/10.1111\/imr.12966","DOI":"10.1111\/imr.12966"},{"key":"3462_CR8","doi-asserted-by":"publisher","unstructured":"Illarramendi X (2021) A promising whole-blood biomarker to aid leprosy control. EBioMedicine 68:103413. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103413","DOI":"10.1016\/j.ebiom.2021.103413"},{"key":"3462_CR9","doi-asserted-by":"publisher","unstructured":"Geluk A et al (2012) New biomarkers with relevance to Leprosy diagnosis Applicable in Areas Hyperendemic for Leprosy. J Immunol 188(10):4782\u20134791. https:\/\/doi.org\/10.4049\/jimmunol.1103452","DOI":"10.4049\/jimmunol.1103452"},{"key":"3462_CR10","doi-asserted-by":"publisher","unstructured":"Soares BA, Stanke Scandelari JP, Wagatuma Bottolo BM, de Moura J (2020) Engineered biomarkers for immunodiagnosis of leprosy. in Precision Medicine for investigators, practitioners and providers. Elsevier, pp 309\u2013317. https:\/\/doi.org\/10.1016\/B978-0-12-819178-1.00030-7.","DOI":"10.1016\/B978-0-12-819178-1.00030-7"},{"key":"3462_CR11","doi-asserted-by":"publisher","unstructured":"TiemiNagao-Dias A et al (2019) Serum Anti-PGL-1 IgG, IgM, and IgA in a 3-Year Follow-up Study of 4-15-Year-old Leprosy Contacts., Pediatr Infect Dis J, 38(9):e193\u2013e198, https:\/\/doi.org\/10.1097\/INF.0000000000002337","DOI":"10.1097\/INF.0000000000002337"},{"key":"3462_CR12","doi-asserted-by":"publisher","unstructured":"Bazan-Furini R et al (2011) Early detection of leprosy by examination of household contacts, determination of serum anti-PGL-1 antibodies and consanguinity., Mem Inst Oswaldo Cruz, 106(5):536\u201340, https:\/\/doi.org\/10.1590\/s0074-02762011000500003","DOI":"10.1590\/s0074-02762011000500003"},{"key":"3462_CR13","doi-asserted-by":"publisher","unstructured":"de Macedo AC et al (2018) Serum anti-phenolic glycolipid-1 IgA correlates to IgM isotype in leprosy patients: a possible candidate for seroepidemiological surveys? J Clin Lab Anal, 32(3), https:\/\/doi.org\/10.1002\/jcla.22276","DOI":"10.1002\/jcla.22276"},{"issue":"1","key":"3462_CR14","first-page":"238","volume":"32","author":"MAS Abdou","year":"2019","unstructured":"Abdou MAS (2019) Relation between anti-phenolic glycolipid-1 seropositivity and other factors among the household contacts of Egyptian leprosy cases. Menoufia Med J 32(1):238\u2013243","journal-title":"Menoufia Med J"},{"key":"3462_CR15","doi-asserted-by":"publisher","unstructured":"Alrehaili J (2023) Leprosy classification, clinical features, epidemiology, and host immunological responses: failure of eradication in 2023. Cureus 15(9):e44767. https:\/\/doi.org\/10.7759\/cureus.44767","DOI":"10.7759\/cureus.44767"},{"key":"3462_CR16","doi-asserted-by":"publisher","unstructured":"Penna MLF, Penna GO, Iglesias PC, Natal S, Rodrigues LC (2016) Anti-PGL-1 positivity as a risk marker for the development of Leprosy among contacts of Leprosy cases: systematic review and Meta-analysis. PLoS Negl Trop Dis 10(5):e0004703. https:\/\/doi.org\/10.1371\/journal.pntd.0004703","DOI":"10.1371\/journal.pntd.0004703"},{"key":"3462_CR17","doi-asserted-by":"publisher","unstructured":"de Alecrin ES, de Oliveira ALG, Guimar\u00e3es NS, Lyon S, Martins MAP, Rocha MO (2022) Factors associated with the development of leprosy in Brazilian contacts: a systematic review., Rev Inst Med Trop Sao Paulo, 64:e55, https:\/\/doi.org\/10.1590\/S1678-9946202264055","DOI":"10.1590\/S1678-9946202264055"},{"key":"3462_CR18","unstructured":"World Health Organization (2021) Towards zero leprosy: global Leprosy (Hansen\u2019s disease) Strategy 2021\u20132030, Geneva, Switzerland"},{"issue":"2","key":"3462_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4103\/mmj.mmj_304_19","volume":"34","author":"A Maraee","year":"2021","unstructured":"Maraee A, Farag AGA, Ibrahem RAL, Sharshar P (2021) Epidemiology of leprosy in Nile Delta, Egypt: a 5-year survey. Menoufia Med J 34(2):451. https:\/\/doi.org\/10.4103\/mmj.mmj_304_19","journal-title":"Menoufia Med J"},{"key":"3462_CR20","doi-asserted-by":"publisher","unstructured":"Hegazy AA, Abdel-Hamid IA, Ahmed EF, Hammad SM, Hawas SA (2002) Leprosy in a high\u2010prevalence Egyptian village: epidemiology and risk factors. Int J Dermatol 41(10):681\u2013686. https:\/\/doi.org\/10.1046\/j.1365-4362.2002.01602.x","DOI":"10.1046\/j.1365-4362.2002.01602.x"},{"key":"3462_CR21","doi-asserted-by":"publisher","unstructured":"Pescarini JM et al (2018) Socioeconomic risk markers of leprosy in high-burden countries: a systematic review and meta-analysis. PLoS Negl Trop Dis 12(7):e0006622. https:\/\/doi.org\/10.1371\/journal.pntd.0006622","DOI":"10.1371\/journal.pntd.0006622"},{"key":"3462_CR22","doi-asserted-by":"publisher","first-page":"841030","DOI":"10.3389\/fmed.2022.841030","volume":"9","author":"DE Antunes","year":"2022","unstructured":"Antunes DE et al (2022) Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: a 10-year retrospective cohort study. Front Med (Lausanne) 9:841030. https:\/\/doi.org\/10.3389\/fmed.2022.841030","journal-title":"Front Med (Lausanne)"},{"key":"3462_CR23","doi-asserted-by":"publisher","unstructured":"Carvalho APM, Corr\u00eaa A, Oliveira, Lana FCF (2015) Factors associated with anti-phenolic glycolipid-I seropositivity among the household contacts of leprosy cases, BMC Infect Dis, 15(1):219. https:\/\/doi.org\/10.1186\/s12879-015-0955-3","DOI":"10.1186\/s12879-015-0955-3"},{"key":"3462_CR24","doi-asserted-by":"publisher","unstructured":"Bakker MI (2004) Population survey to determine risk factors for Mycobacterium leprae transmission and infection, Int J Epidemiol, 33(6):1329\u20131336. https:\/\/doi.org\/10.1093\/ije\/dyh266","DOI":"10.1093\/ije\/dyh266"},{"key":"3462_CR25","doi-asserted-by":"crossref","unstructured":"Barreto JG, Guimar\u00e3es LDS, Le\u00e3o MRN, Ferreira DVG, Lima RADA, Salgado CG (2011) Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon., Lepr Rev, 82(4):358\u201370","DOI":"10.47276\/lr.82.4.358"},{"key":"3462_CR26","doi-asserted-by":"publisher","unstructured":"Romero-Montoya M, Beltran-Alzate JC, Cardona-Castro N (2017) Evaluation and monitoring of Mycobacterium leprae Transmission in Household contacts of patients with Hansen\u2019s Disease in Colombia. PLoS Negl Trop Dis 11(1):e0005325. https:\/\/doi.org\/10.1371\/journal.pntd.0005325","DOI":"10.1371\/journal.pntd.0005325"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03462-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03462-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03462-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T09:06:45Z","timestamp":1731143205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03462-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3462"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03462-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with all relevant ethical regulations. The experimental protocol was established according to the International Ethical Guidelines for Biomedical Research Involving Human Subjects and were approved by The Ethical Committee Review Board, Helwan University, Cairo, Egypt (approval code \u201c462020\u201d). Informed consent was obtained from all enrolled participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}